Top Story

HIV did not affect HCC recurrence or survival after LT

March 2, 2015

Survival and recurrence rates were unaffected by HIV infection among patients who underwent liver transplantation for hepatocellular carcinoma, according to a poster presentation at CROI 2015.

In this prospective cohort study, 74 patients with HIV and HCC who underwent liver transplantation across 22 clinical centers in Spain were matched in a 1:3 ratio with 222 non–HIV-infected patients with HCC who underwent liver transplantation to determine whether HIV infection affected survival or recurrence rates for HCC after liver transplantation. Of all the patients, 86% were men and 92% had hepatitis C virus infection. At the time of liver transplantation, 96% of patients with HIV were undergoing antiretroviral therapy. Median follow-up was 46 months.

In the Journals

Chronic fungal lesions predisposed to malignancy

March 2, 2015
Researchers in Brazil documented seven cases of squamous cell carcinoma that resulted from chronic chromoblastomycosis in the Brazilian Amazon state…
Meeting News Coverage

HIV prevention yields significant lifetime medical cost savings

March 1, 2015
SEATTLE — Considering the high lifetime medical costs of HIV treatment in the United States, the possible cost savings of HIV prevention is significant, according…
thumbnail for video 4083453350001 Meeting News CoverageVideo

Video: Action needed to reduce CVD risks in HIV patients

February 28, 2015
SEATTLE — Steven Grinspoon, MD, of the Massachusetts General Hospital and Harvard Medical School, gives an overview of his CROI 2015 plenary session discussing…
Meeting News Coverage

Repeat testing necessary to detect HIV among infants receiving ART via breast-feeding

February 27, 2015
SEATTLE — WHO recommendations for HIV testing 6 weeks after breast-feeding cessation may need to be re-evaluated, as study findings presented at CROI 2015 suggest…
More News Headlines »
CME
Regimen Selection in HIV

Regimen Selection in HIV: Considering New Options to Optimize Outcomes
Monograph

This activity is supported by an educational grant from Gilead Sciences Medical Affairs.

More than 2 decades into the antiretroviral therapy (ART) era, numerous options are available for HIV treatment. The…
More »
Meeting News Coverage Video
thumbnail for video 4083320513001

Video: Highlights in cancer and HIV treatments at CROI 2015

February 27, 2015
Infectious Disease News Editorial Board member Paul Volberding, MD, reviews HIV and cancer treatment data presented…
More »
CME
j526

Regimen Selection in HIV: Considering New Options to Optimize Outcomes

This activity is supported by an educational grant from Gilead Sciences Medical Affairs.

More than two decades into the antiretroviral therapy (ART) era, there are numerous options for HIV treatment. The goal…
More »